Search
for
Sort by
Research 571–600 of 1000+
- A liquid chromatography/tandem mass spectrometry method for determination of aristolochic acid‐I in rat plasma
- Flavonoids and saponins: What have we got or missed?
- Determination of finasteride in human plasma by HPLC-MS
- Novel Dual Soft Drug Strategy Enables Development of Topical Androgen Receptor Antagonists with Enhanced Efficacy and Optimized Safety for Androgenetic Alopecia
- Method development and estimation of minoxidil by gas chromatography
- Predstanormix Duo – a new domestic combination drug for the treatment of lower urinary tract dysfunction symptoms associated with BPH.
- Determination of candesartan in human plasma by HPLC-MS-MS
- HPLC-APCI-MS Determination of Finasteride in Human Plasma
- Discovery of Orally Available Prodrugs of Itaconate and Derivatives
- Topical cyclosporin A treatment in psoriasis and other dermatological diseases: Theoretical and practical aspects
- Selected Traditional Herbs for Alopecia and Hair Health: A Scientific Review
- What does the research say about androgen use and cerebrovascular events?
- Molecular Docking Studies and ADME-Tox Prediction of Phytocompounds from Lycopersicon esculentum mill. as a Drug Candidate for Alopecia Treatment
- Tether-induced tenosynovitis: The importance of an intact skin barrier
- 267 Single- and multiple-ascending dose studies of DS-2325a, a KLK5 inhibitor for the treatment of Netherton syndrome
- Study on Plasma Concentration and Bioavailability of Wogonin in Beagle's Dogs
- Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
- Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride?
- A phase I study of MK-5108, an oral aurora A kinase inhibitor, in both monotherapy and in combination with docetaxel in patients with advanced solid tumors.
- Nanoemulgel: For Promising Topical and Systemic Delivery
- Patents on Nanoparticulate Drug Delivery Systems - A Review
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Redefining Drug Discovery: A Review of Drug Repurposing –Approaches, Benefits and Breakthroughs
- Systemic Antifungals
- Safety profile of CAP7.1 obtained during Phase I Trial in adult patients with refractory malignancies
- Azathioprine
- Rational Design and Synthesis of 4-((1<i>R</i>,2<i>R</i>)-2-Hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile (PF-998425), a Novel, Nonsteroidal Androgen Receptor Antagonist Devoid of Phototoxicity for Dermatological Indications
- Review of Fluconazole Properties and Analytical Methods for Its Determination
- Recent advances in drug repositioning and rediscovery for different therapeutic activities utilizing updated technological approaches
- Non-clinical safety evaluation and risk assessment to human of aleglitazar, a dual PPAR α/γ agonist, and its major human metabolite